Together, these data in combination with the patient’s clinical history laboratory tests, HE morphological features, reliable immunohistochemical results, and genetic testing results, the diagnosis was CD20-negative DLBCL of the right temporal lobe. This evidence concerns the gene MS4A1 and diffuse large B-cell lymphoma.